Charles
Latest round
- Seed
Last raised
- May 2022
Total raised
- $4.2M
Investors
- 2
About Charles
Based in Paris, France, and founded in 2019 by its co-founders Simon Burellier and Olivier Algoud, Charles SAS operates as a digital clinic for adult patients' issues and their daily health concerns. Charles SAS provides an integrated digital platform that addresses chronic health issues in men, such as sexual health, hair loss, or insomnia. The company allows personalized care according to the doctor's recommendations: home delivery of treatments (prescription at the doctor's discretion), consultation services via videoconference, messaging or telephone, digital therapy, medical devices, and psychological follow-up.
Who invested in Charles
2 investors across 1 round
See all investors in Charles
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 12, 2022
Amount
$4.2M
Investors
Questions about Charles
Who invested in Charles?
Charles has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Charles raised?
Charles has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Charles last raise money?
Charles's most recent round on record is a Seed, in May 2022.
What does Charles do?
Based in Paris, France, and founded in 2019 by its co-founders Simon Burellier and Olivier Algoud, Charles SAS operates as a digital clinic for adult patients' issues and their daily health concerns.
Where is Charles headquartered?
Charles is headquartered in Paris, France.
Which VCs invest in companies like Charles?
Among active investors with capital left to deploy, Index Ventures, Forbion, Balderton Capital and Sofinnova Partners back healthcare companies at Charles's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like Charles? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.